SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services
SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector.
The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions.
"Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the unique needs of Ireland's tech sector, especially large data centers, with world-class services delivered locally."
Strategically located in Shannon, County Clare, the new site positions SK tes to offer rapid, secure, and compliant services for every stage of the IT lifecycle-from equipment deployment and maintenance, to decommissioning and certified data destruction. With its ability to quickly scale operations, the facility is built to meet the evolving needs of both indigenous Irish companies and multinationals operating within the country.
"This isn't just another facility-it's a statement of intent," said Thomas Holberg, Chief Operating Officer at SK tes. "We're here to support Ireland's technology leaders as they build a more sustainable digital future. Our Shannon site will support Irish businesses in achieving their reuse and sustainability targets while creating meaningful employment and strengthening the region's role as a technology and innovation hub."
SK tes' investment comes as Ireland continues to attract major global data center infrastructure and tech companies, while placing increased emphasis on sustainability and resource recovery. With its ability to extend the lifecycle of technology assets, securely destroy data, and responsibly recycle materials, the new site directly supports the goals set out in Ireland's Climate Action Plan and Circular Economy Strategy.
The Shannon site joins SK tes' growing global network, which includes over 40 owned facilities across 22 countries, providing consistent, secure, and sustainable IT lifecycle solutions to customers around the world.
About SK tes:
Since our formation in 2005, SK tes, a subsidiary of SK ecoplant, has grown to become a global leader in sustainable battery recycling and technology lifecycle services. We provide comprehensive services for battery recycling, extracting scarce materials from used batteries at purity rates high enough that they can be reused in the manufacturing supply chain.
SK tes has over 40 owned facilities across 22 countries offering unmatched service-level consistency, consistent commercials, lower logistics costs, local compliance experts in-region, support in local time zones and languages, and a deep understanding of transboundary movement globally.
For more information about SK tes and global capabilities, please visit our website www.sktes.com.
Contact Information
Maria Penaloza
Media And Content Strategist
mariap@accessnewswire.com
Kristine Kearney
kristine.kearney@sktes.com
+44 7706 352 702
SOURCE: SK tes
Related Images



View the original press release on ACCESS Newswire
SK tes

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release
Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new
Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release
Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie
TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea
BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T
Picktan Capital Eyes a Public Listing on the LSE22.4.2025 09:10:00 CEST | Press release
Picktan Capital Explores Strategic Move Toward Public Listing on the London Stock Exchange in 2026. LONDON, UK / ACCESS Newswire / April 22, 2025 / Picktan Capital, the London-headquartered wealth management firm managing over $7 billion in client assets globally, has confirmed it is in active discussions with several major London-based investment banks to explore the possibility of a public listing on the London Stock Exchange (LSE) in 2026. The firm, known for its disciplined investment approach and bespoke wealth solutions, has formally notified its board of directors and shareholders of its intent to pursue a potential IPO. A strategic review process is currently underway to evaluate the most effective path to the public markets. At a recent shareholder meeting, the proposal to move forward with the listing received unanimous approval, highlighting widespread confidence in the company's direction, leadership, and future growth prospects. Founded with a mission to provide tailored,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom